Hypertension and chronotherapy: Shifting the treatment paradigm

American Journal of Hypertension

Volumn 14, Issue 9 II, 2001, Pages

  Prisant, L Michael ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Chronobiology; Hypertension; Novel drug delivery systems; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT; NIFEDIPINE; NIFEDIPINE GITS; VERAPAMIL; VERELAN PM;

ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CHRONOTHERAPY; CIRCADIAN RHYTHM; CONTROLLED RELEASE FORMULATION; HOMEOSTASIS; HUMAN; HYPERTENSION; OPTIC NERVE DISEASE; PRIORITY JOURNAL;

EID: 0034834792     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)02173-2     Document Type: Article

References (23)

1. Biologic rhythms and medicine
2. Medical chronobiology: Concepts and applications
3. Circadian blood pressure patterns in ambulatory hypertensive patients: Effects of age
4. Circadian variation of blood-pressure
5. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death
6. Circadian rhythms and clinical medicine with applications for hypertension
7. Circadian variation in cardiovascular events
8. Cyclic and circadian variations in cardiovascular events
9. Chronotherapeutics for cardiovascular disease
10. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension
11. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers
12. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine
13. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view
14. Drug delivery systems for antihypertensive agents
15. Novel drug-delivery systems for hypertension
16. Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning
17. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension
18. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product
19. The use of chronotherapeutics to achieve maximal blood pressure reduction during the early morning blood pressure surge
20. Pharmacology of cardiovascular chronotherapeutic agents
21. Verapamil revisted: A transition in novel drug delivery systems and outcomes
22. A steady-state evaluation of the bioavailability of chronotherapeutic oral drug absorption system verapamil PM after nighttime dosing versus immediate-acting verapamil dosed every eight hours
23. The circadian pattern of blood pressure: Cardiovascular risk and therapeutic opportunities